Presentations on Open Aperture, Apertura's material transfer agreement program, describe how open academic access to TfR1 CapX can unlock innovation and collaboration across the field
New PTC Harmony thermal cycler line expands access to reliable, high‑performance PCR across academic and biopharma laboratories
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
A study led by Karl Landsteiner University shows that the disease affects whole-brain communication networks, and that this may help predict survival
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Vote for the products that have made the most difference to your research for the chance to win a $100 Amazon Gift Card (or equivalent currency)
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies
Expanded CFTR variant coverage designed to align with updated professional recommendations
Equipped with the READY System to make structural biology research accessible to more labs
Prospective UT MD Anderson study shows RNA analysis expands on treatment options beyond DNA testing
Dr. Becky Upton, President of Pistoia Alliance, looks to the future of lab innovation in this guest editorial
Showcased at AACR 2026 with data from leading research institutions, including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ)
Biodesix, Inc. to present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting
Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies.
This approach may eventually help guide personalized treatment decisions for patients diagnosed with these cancers
The Content Innovation Engine integrates Akoya's spatial biology platform and Quanterix's immunoassay infrastructure to unlock cancer biology and accelerate clinical application
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic NSCLC
The AACR will present the 2026 AACR Award for Lifetime Achievement in Cancer Research to Dr. James P. Allison, Fellow of the AACR Academy, during the AACR Annual Meeting 2026
The AACR will present the 2026 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research during the AACR Annual Meeting 2026
The AACR will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026
Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications
Meeting co‑chairs Dr. Paul Mischel and Dr. Alice Shaw share the themes, challenges, and scientific momentum shaping this year’s must‑attend event
